Epilepsia partialis continua and generalized nonconvulsive status epilepticus during the course of argininemia: A report on two cases

Neuropediatrics

Volumn 45, Issue 2, 2014, Pages 123-128

  Grioni, D ^a   Furlan, F ^b   Canonico, F ^a   Parini, R ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

argininemia; epilepsia partialis continua; levetiracetam; status epilepticus; urea cycle disorders; valproic acid

Indexed keywords

4 PHENYLBUTYRIC ACID; ARGININE; ETIRACETAM; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; ATROPHY; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; CASE REPORT; CHILD; CONFUSION; DISEASE COURSE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; EPILEPTIC STATE; FOLLOW UP; HUMAN; HYPERAMMONEMIA; HYPERARGININEMIA; MAINTENANCE DRUG DOSE; MALE; MUSCLE POTENTIAL; NONCONVULSIVE STATUS EPILEPTICUS; PARAPLEGIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN RESTRICTION; SCHOOL CHILD; SEIZURE; SENSORIMOTOR CORTEX; SPASTIC PARAPLEGIA; STUPOR; TONIC CLONIC SEIZURE; COMPLICATION; EPILEPSIA PARTIALIS CONTINUA; EPILEPSY, GENERALIZED;

CHILD; CHILD, PRESCHOOL; EPILEPSIA PARTIALIS CONTINUA; EPILEPSY, GENERALIZED; HUMANS; HYPERARGININEMIA; MALE;

EID: 84897110355     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0033-1360479     Document Type: Article

References (12)

1. Terheggen H. G., Schwenk A., Lowenthal A., Van Sande M., Colombo J. P. Argininaemia with arginase deficiency. [letter] Lancet: 1969; 294 7623 748 749
2. Terheggen H. G., Schwenk A., Lowenthal A., et al. Hyperargininemia with arginase deficiency. A new familial metabolic disease. I. Clinical Studies. Z Kinderheilkd.: 1970; 107 4 298 312
3. Vilarinho L., Senra V., Vilarinho A., et al. A new case of argininaemia without spastic diplegia in a Portuguese male. J Inherit Metab Dis: 1990; 13 5 751 752 (Pubitemid 20296480)
4. Christmann D., Hirsch E., Mutschler V., Collard M., Marescaux C., Colombo J. P. Late diagnosis of congenital argininemia during administration of sodium valproate. Rev Neurol (Paris): 1990; 146 12 764 766
5. Carvalho D. R., Brum J. M., Speck-Martins C. E., et al. Clinical features and neurologic progression of hyperargininemia. Pediatr Neurol: 2012; 46 6 369 374
6. Kozevnikov A. Y.. A peculiar type of cortical epilepsy (epilepsia corticalis sive partialis continua). Miditsinskoe Obozreni 1894;42/14:33-62. Asher DM, trans-ed. Chronic encephalitis and epilepsy. In: Andermann F., ed. Rasmussen's Syndrome. Boston, MA Butterworth-Heinemann: 1991; 245 61
7. Engel J. Jr. Report of the ILAE Classification Core Group Report of the ILAE classification core group. Epilepsia: 2006; 47 9 1558 1568 (Pubitemid 44393870)
8. Bien C. G., Elger C. E. Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord: 2008; 10 1 3 7 (Pubitemid 351507319)
9. Glauser T. A., Cnaan A., Shinnar S., et al. Childhood Absence Epilepsy Study Team. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia: 2013; 54 1 141 155
10. Scaglia F., Lee B. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet: 2006; 142C 2 113 120
11. Carvalho D. R., Farage L., Martins B. J., Brum J. M., Speck-Martins C. E., Pratesi R. Brain MRI and magnetic resonance spectroscopy findings in patients with hyperargininemia. J Neuroimaging: 2012; (e-pub ahead of print) doi: 10.1111/j.1552-6569.2012.00739x
12. Patay Z. Metabolic disorders. In: Tortori-Donati P., Rossi A., eds. Pediatric Neuroradiology: Brain, Head, Neck and Spine. Berlin Heidelberg, Germany Springer-Verlag: 2005;:Chap 13, pp. 544 721